
Provider of Atrial Fibrillation Electrophysiology and Peripheral Vascular Intervention Solutions
Click the blue words to follow us
SHINEYOMEDICAL



April 9-12, 2026The 93ʳᵈ China International Medical Equipment FairComing Soon! As the largest and most influential medical device industry event in the Asia-Pacific region, this year's exhibition brings together cutting-edge technologies and innovative achievements from around the globe to discuss the new future of the healthcare industry.
ShineyoMedical sincerely invites you to visit our booth for exchange and discussion, and to explore new opportunities in the medical field together.
1. ShineyoMedical Exhibits Make a Heavyweight Appearance
Part.01
Part.02

2. ShineyoMedical Exhibition Area Location







3. About ShineyoMedical
【ShineyoMedical RhythPulse®-PFA System】
ShineyoMedical's RhythPulse®-PFA System is the first approved Pulse Field Ablation (PFA) system in China that integrates multi-channel, large focal points, and targeted ablation. It is mainly used for treating drug-refractory and recurrent atrial fibrillation and other types of rapid arrhythmia. Its core advantages include:
Large Focal Spot Design:Using the world's first 10mm ring ablation catheter, a single discharge can cover a lesion area with a diameter of 10mm, increasing the ablation efficiency by more than three times compared to traditional technology.
Targeted Ablation Technology:Equipped with an intelligent contact detection module, it monitors the contact status between the electrode and myocardial tissue in real time, reducing the risk of hemolysis caused by ineffective discharge. Postoperative plasma free hemoglobin content decreased by 50%.
Excellent clinical validation:In a clinical trial involving 151 cases, the immediate success rate was 100%, and the success rate for atrial fibrillation treatment at 12 months post-operation reached 85.07%, achieving internationally leading standards.